S100A4 and cancer: As a biomarker, the detection of S100A4 level in tumor tissues or non-invasively in body liquid specimens could predict prognosis and metastasis of cancer patients in early stages and the inhibition of S100A4 expression also restricted the metastasis potential in vivo [102].